Feener Edward P.
Former Officer at KALV
- Sold, on record
- $4.6M
- Dollars the filings state
- Form 4 sales
- 23
- Latest May 20, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KALVKalVista Pharmaceuticals, Inc.Former Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KALVNo planNov 20, 2023 2023
Sold 4,958 shares at $8.23 ($41k)
Feener Edward P., Chief Scientific Officer
No 10b5-1 planSold 5.8% of holdings ($698k position)79,828 shares left2.8x usual sizeFiling
- 2 Form 144 notice KALVNoticeJan 8, 2024 +49 days
Filed to sell 59,891 shares ($779k)
Feener Edward P., Officer
10b5-1 plan29.8x usual sizeFiling
- 3 Form 4 sale KALVUnusualJan 9, 2024 +1 day
Sold 17,321 shares at $13.01 ($225k)
Feener Edward P., Chief Scientific Officer
10b5-1 planSold 21.7% of holdings ($1M position)62,507 shares left8.6x usual sizeFollows a Form 144Filing
- 4 Form 4 sale KALVUnusualJan 11, 2024 +2 days
Sold 22,679 shares at $13.03 ($296k)
Feener Edward P., Chief Scientific Officer
10b5-1 planSold 36.3% of holdings ($814k position)39,828 shares left10.2x usual sizeFollows a Form 144Filing
- 5 Form 4 sale KALVUnusualFeb 14, 2024 +34 days
Sold 28,171 shares at $15.01 ($423k)
Feener Edward P., CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 28.2% of holdings ($1.5M position)71,657 shares left7.8x usual sizeFollows a Form 144Filing
- 6 Form 4 sale KALVUnusualFeb 20, 2024 +6 days
Sold 28,288 shares at $14.07 ($398k)
Feener Edward P., CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 31.3% of holdings ($1.3M position)62,157 shares left5.7x usual sizeFiling
- 7 Form 4 sale KALVRoutineMay 20, 2024 +90 days
Sold 8,088 shares at $11.76 ($95k)
Feener Edward P., CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 10% of holdings ($952k position)72,858 shares left1.6x usual sizeFiling
- 8 Form 144 notice KALVNoticeJul 16, 2024 +57 days
Filed to sell 13,972 shares ($214k)
Feener Edward P., Former Officer
No 10b5-1 plan2.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | Jul 16, 2024 | KALV | Former Officer | Form 144 notice | 13,972 | $214k | Notice | SEC | |
| May 20, 2024 | May 21, 2024 | KALV | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 8,088 | $95k | 10.0% | Routine | SEC |
| Feb 20, 2024 | Feb 21, 2024 | KALV | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 28,288 | $398k | 31.3% | Unusual | SEC |
| Feb 14, 2024 | Feb 16, 2024 | KALV | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 28,171 | $423k | 28.2% | Unusual | SEC |
| Jan 11, 2024 | Jan 12, 2024 | KALV | Chief Scientific Officer | Form 4 sale | 22,679 | $296k | 36.3% | Unusual | SEC |
| Jan 9, 2024 | Jan 10, 2024 | KALV | Chief Scientific Officer | Form 4 sale | 17,321 | $225k | 21.7% | Unusual | SEC |
| Jan 8, 2024 | Jan 8, 2024 | KALV | Officer | Form 144 notice | 59,891 | $779k | Notice | SEC | |
| Nov 20, 2023 | Nov 21, 2023 | KALV | Chief Scientific Officer | Form 4 sale | 4,958 | $41k | 5.8% | No plan | SEC |
| Aug 18, 2023 | Aug 21, 2023 | KALV | Chief Scientific Officer | Form 4 sale | 4,976 | $53k | 6.4% | No plan | SEC |
| May 18, 2023 | May 19, 2023 | KALV | Chief Scientific Officer | Form 4 sale | 1,786 | $18k | 2.6% | No plan | SEC |
| Feb 17, 2023 | Feb 23, 2023 | KALV | Chief Scientific Officer | Form 4 sale | 2,228 | $17k | 3.3% | Plan not stated | SEC |
| Nov 18, 2022 | Nov 21, 2022 | KALV | Chief Scientific Officer | Form 4 sale | 530 | $3k | 0.8% | Plan not stated | SEC |
| Aug 17, 2022 | Aug 19, 2022 | KALV | Chief Scientific Officer | Form 4 sale | 532 | $8k | 0.9% | Plan not stated | SEC |
| Nov 1, 2021 | Nov 3, 2021 | KALV | Chief Scientific Officer | Form 4 sale | 6,000 | $108k | 72.9% | Unusual | SEC |
| Aug 2, 2021 | Aug 4, 2021 | KALV | Chief Scientific Officer | Form 4 sale | 6,000 | $123k | 42.2% | Unusual | SEC |
| Jun 2, 2021 | Jun 3, 2021 | KALV | Chief Scientific Officer | Form 4 sale | 34,000 | $908k | 70.5% | Unusual | SEC |
| May 3, 2021 | May 6, 2021 | KALV | Chief Scientific Officer | Form 4 sale | 6,000 | $149k | 10.0% | Plan not stated | SEC |
| Feb 23, 2021 | Feb 25, 2021 | KALV | Chief Scientific Officer | Form 4 sale | 31,000 | $1M | 36.4% | Unusual | SEC |
| Nov 2, 2020 | Nov 4, 2020 | KALV | Chief Scientific Officer | Form 4 sale | 6,000 | $103k | 7.6% | Plan not stated | SEC |
| Oct 21, 2020 | Oct 22, 2020 | KALV | Chief Scientific Officer | Form 4 sale | 16,907 | $303k | 17.7% | Unusual | SEC |
| Oct 16, 2020 | Oct 20, 2020 | KALV | Chief Scientific Officer | Form 4 sale | 993 | $17k | 1.0% | Plan not stated | SEC |
| Feb 5, 2020 | Feb 7, 2020 | KALV | Chief Scientific Officer | Form 4 sale | 100 | $2k | 0.1% | Plan not stated | SEC |
| Jul 23, 2019 | Jul 24, 2019 | KALV | Chief Scientific Officer | Form 4 sale | 3,300 | $61k | 3.3% | Plan not stated | SEC |
| Apr 17, 2019 | Apr 18, 2019 | KALV | Chief Scientific Officer | Form 4 sale | 4,000 | $100k | 3.8% | Plan not stated | SEC |
| Jan 16, 2019 | Jan 18, 2019 | KALV | Chief Scientific Officer | Form 4 sale | 4,000 | $78k | 3.7% | Plan not stated | SEC |